Instituto Nacional do Cancer - INCA

Rio de Janeiro, Rio de Janeiro 20560-120

0 studies enrolling now · 3 studies all time

What they study most

Breast Neoplasms, Malignant Melanoma, Neoplasms, Renal Cell Carcinoma

Studies at this site

• A Study on the Effect of Vemurafenib on the Pharmacokinetics of a Single Dose of Tizanidine in Patients With BRAFV600 Mutation-Positive Metastatic Malignancies — Completed
• Study Comparing Bevacizumab + Temsirolimus vs. Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects — Completed
• Study Of CP-751,871 In Combination With Exemestane In Postmenopausal Women With Hormone Receptor Positive Advanced Breast Cancer — Stopped early